Health, beliefs, and faith: HPV vaccine uptake intent among Catholic, Evangelical, and mainline protestant parents.

Jeanine P D Guidry, Shillpa Naavaal, Linnea I Laestadius, Carrie A Miller, Gina Zurlo, Candace W Burton, Kellie E Carlyle, Julie Russo, Paul B Perrin
Author Information
  1. Jeanine P D Guidry: Department of Communication and Cognition, Tilburg University, Tilburg, The Netherlands. ORCID
  2. Shillpa Naavaal: Department of Dental Public Health and Policy, Virginia Commonwealth University School of Dentistry, Richmond, VA, USA.
  3. Linnea I Laestadius: Joseph J. Zilber College of Public Health, University of Wisconsin-Milwaukee, Milwaukee, WI, USA. ORCID
  4. Carrie A Miller: Department of Family Medicine and Population Health, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
  5. Gina Zurlo: Harvard Divinity School, Cambridge, MA, USA.
  6. Candace W Burton: School of Nursing, University of Nevada-Las Vegas, Las Vegas, NV, USA. ORCID
  7. Kellie E Carlyle: School of Public Health, Virginia Commonwealth University, Richmond, VA, USA.
  8. Julie Russo: School of Public Health, Virginia Commonwealth University, Richmond, VA, USA.
  9. Paul B Perrin: Department of Data Science, Department of Psychology, University of Virginia, Charlottesville, VA, USA.

Abstract

The HPV vaccine has the potential to prevent nearly 92% of HPV-related cancer cases, yet its uptake remains suboptimal. While well-documented barriers to HPV vaccine uptake include inadequate knowledge and lack of provider recommendation, religious preferences have emerged as another crucial factor influencing vaccination decisions. This study examined the interrelatedness of religion, beliefs, and HPV vaccination uptake among children among Catholic, Evangelical, and Mainline Protestant parents. A nationally representative survey was conducted among 1,068 U.S. parents from one of three major Christian denominations: Catholic, Evangelical, or Mainline Protestant. We examined the extent to which demographic factors, constructs from the Health Belief Model (perceived severity, susceptibility, benefits, barriers, self-efficacy, and cues to action), and faith-based support variables contributed to HPV vaccination decisions among parents from the specified religious denominations. Among the surveyed parents, 72.3% indicated that their child had received the HPV vaccine, revealing a substantial but incomplete uptake rate. Notably, no statistically significant differences were observed in vaccination rates across the three denominational groups. Perceived HPV vaccine benefits ( < .001), perceived barriers ( < .001) and perceived self-efficacy ( = .013) were strongly associated. Parents reporting that their child's healthcare provider asked them about the vaccine ( < .001) and those more receptive to faith-based support for HPV vaccination ( = .049) were more likely to report child HPV vaccine uptake. To enhance HPV vaccine uptake among the examined religious denominations, strengthening provider-parent communication regarding the HPV vaccine and fostering partnerships between healthcare providers and supportive religious congregations can serve as powerful levers for promoting vaccination acceptance and compliance.

Keywords

References

  1. BMJ. 2024 Jan 16;384:e076542 [PMID: 38228339]
  2. Am J Prev Med. 2019 Apr;56(4):591-602 [PMID: 30773231]
  3. Int J Cancer. 2015 Jun 15;136(12):2752-60 [PMID: 25043222]
  4. JAMA Netw Open. 2021 Sep 1;4(9):e2127582 [PMID: 34591103]
  5. Ann Behav Med. 2012 Oct;44(2):171-80 [PMID: 22547155]
  6. J Med Internet Res. 2022 Feb 1;24(2):e35552 [PMID: 35007204]
  7. MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):698-702 [PMID: 31415491]
  8. Vaccine. 2022 Jul 30;40(32):4654-4662 [PMID: 35750541]
  9. Vaccine. 2013 Apr 12;31(16):2011-23 [PMID: 23499565]
  10. Int Q Community Health Educ. 2013-2014;34(1):101-17 [PMID: 24366025]
  11. Sex Transm Dis. 2011 Mar;38(3):197-204 [PMID: 20838362]
  12. Vaccine. 2020 Jul 22;38(34):5498-5506 [PMID: 32593606]
  13. BMC Public Health. 2011 Jan 06;11(1):15 [PMID: 21211000]
  14. Public Health. 2014 Mar;128(3):268-73 [PMID: 24529635]
  15. J Behav Med. 2023 Apr;46(1-2):179-184 [PMID: 34981306]
  16. Health Educ Monogr. 1978 Winter;6(4):394-405 [PMID: 299611]
  17. Int J Environ Res Public Health. 2022 Jul 22;19(15): [PMID: 35897301]
  18. Hum Vaccin Immunother. 2019;15(7-8):1688-1696 [PMID: 30427755]
  19. Hum Vaccin Immunother. 2019;15(1):113-120 [PMID: 30095325]
  20. Soc Sci Med. 2006 Oct;63(7):1857-69 [PMID: 16765498]
  21. BMJ Med. 2024 Jan 29;3(1):e000726 [PMID: 38293682]
  22. Int J Environ Res Public Health. 2018 Jan 23;15(2): [PMID: 29360785]
  23. Clin Ther. 2014 Jan 1;36(1):24-37 [PMID: 24417783]
  24. MMWR Morb Mortal Wkly Rep. 2013 Sep 13;62(36):741-3 [PMID: 24025755]
  25. Hum Vaccin Immunother. 2020 Nov 1;16(11):2800-2808 [PMID: 32209009]
  26. Sci Rep. 2022 Apr 26;12(1):5966 [PMID: 35474313]
  27. Dent Clin North Am. 2018 Jan;62(1):111-120 [PMID: 29126488]
  28. Public Underst Sci. 2017 Aug;26(6):704-720 [PMID: 26644011]
  29. Soc Sci Med. 2021 Jan;268:113375 [PMID: 32979772]
  30. Prev Med Rep. 2022 Nov 21;31:102067 [PMID: 36439896]
  31. Vaccine. 2023 Feb 10;41(7):1368-1377 [PMID: 36669967]
  32. Vaccine. 2014 Apr 17;32(19):2150-9 [PMID: 24598724]
  33. Am J Infect Control. 2021 Feb;49(2):137-142 [PMID: 33227323]
  34. Acad Pediatr. 2014 Sep-Oct;14(5):497-504 [PMID: 24954170]
  35. Sex Transm Dis. 2013 Mar;40(3):187-93 [PMID: 23403598]
  36. Vaccine X. 2021 Oct 28;9:100121 [PMID: 34805968]
  37. Hum Vaccin Immunother. 2023 Aug 1;19(2):2246502 [PMID: 37671468]
  38. Ethn Dis. 2007 Winter;17(1 Suppl 1):S15-22 [PMID: 17598312]
  39. J Pediatr Nurs. 2022 Jul-Aug;65:10-15 [PMID: 35367855]
  40. Vaccine. 2023 Sep 22;41(41):6127-6133 [PMID: 37659897]
  41. PLoS One. 2021 Apr 16;16(4):e0250123 [PMID: 33861765]
  42. Hum Vaccin Immunother. 2016 Jun 2;12(6):1566-88 [PMID: 26838959]
  43. J Relig Health. 2013 Dec;52(4):1120-30 [PMID: 22076049]
  44. Lancet. 2015 Oct 31;386(10005):1786-94 [PMID: 26159394]
  45. Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1689-1696 [PMID: 34172461]
  46. Public Health. 2021 May;194:245-251 [PMID: 33965796]
  47. Vaccines (Basel). 2023 Oct 21;11(10): [PMID: 37897025]
  48. Hum Vaccin Immunother. 2019;15(1):146-155 [PMID: 30148974]
  49. BMC Public Health. 2013 May 28;13:511 [PMID: 23711160]
  50. Soc Sci Med. 2009 Aug;69(3):475-80 [PMID: 19540642]
  51. Vaccine. 2021 Apr 22;39(17):2416-2423 [PMID: 33775438]
  52. Hum Vaccin Immunother. 2021 Oct 3;17(10):3355-3364 [PMID: 34187310]
  53. J Community Health. 2017 Jun;42(3):522-532 [PMID: 27778139]

Grants

  1. P30 CA177558/NCI NIH HHS

MeSH Term

Humans
Papillomavirus Vaccines
Female
Male
Parents
Adult
Papillomavirus Infections
Health Knowledge, Attitudes, Practice
Vaccination
Patient Acceptance of Health Care
Surveys and Questionnaires
Middle Aged
Child
Catholicism
United States
Adolescent
Young Adult
Protestantism

Chemicals

Papillomavirus Vaccines

Word Cloud

Created with Highcharts 10.0.0HPVvaccineuptakevaccinationamongparentsreligiousbarriersexaminedCatholicEvangelicalperceived<001providerdecisionsreligionbeliefsMainlineProtestantthreeHealthbenefitsself-efficacyfaith-basedsupportdenominationschild = healthcarepotentialpreventnearly92%HPV-relatedcancercasesyetremainssuboptimalwell-documentedincludeinadequateknowledgelackrecommendationpreferencesemergedanothercrucialfactorinfluencingstudyinterrelatednesschildrennationallyrepresentativesurveyconducted1068 USonemajorChristiandenominations:extentdemographicfactorsconstructsBeliefModelseveritysusceptibilitycuesactionvariablescontributedspecifiedAmongsurveyed723%indicatedreceivedrevealingsubstantialincompleterateNotablystatisticallysignificantdifferencesobservedratesacrossdenominationalgroupsPerceived013stronglyassociatedParentsreportingchild'saskedreceptive049likelyreportenhancestrengtheningprovider-parentcommunicationregardingfosteringpartnershipsproviderssupportivecongregationscanservepowerfulleverspromotingacceptancecompliancefaith:intentmainlineprotestanthealthbeliefmodelparentalhesitancy

Similar Articles

Cited By